Cargando…

Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin

Detalles Bibliográficos
Autores principales:	Li, Bo, Zhao, Xin, Zhang, Lei, Cheng, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208168/ https://www.ncbi.nlm.nih.gov/pubmed/34150656 http://dx.doi.org/10.3389/fonc.2021.687841

Ejemplares similares

Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin
por: Li, Bo, et al.
Publicado: (2021)

Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
por: Li, Zhaoqing, et al.
Publicado: (2022)

Isoalantolactone Enhances the Antitumor Activity of Doxorubicin by Inducing Reactive Oxygen Species and DNA Damage
por: Wu, Fengjiao, et al.
Publicado: (2022)

Corrigendum: Decreased DUSP26 Expression Promotes Malignant Behavior in Glioblastoma Cells via Deregulation of MAPK and Akt Signaling Pathway
por: Chen, Jiajia, et al.
Publicado: (2021)

Pictilisib Enhances the Antitumor Effect of Doxorubicin and Prevents Tumor-Mediated Bone Destruction by Blockade of PI3K/AKT Pathway
por: Liang, Chao, et al.
Publicado: (2021)

Rotundic Acid Induces DNA Damage and Cell Death in Hepatocellular Carcinoma Through AKT/mTOR and MAPK Pathways
por: Roy, Gaurab, et al.
Publicado: (2019)

Emodin Interferes With Nitroglycerin-Induced Migraine in Rats Through CGMP-PKG Pathway
por: Sun, Shuding, et al.
Publicado: (2021)

Sensitization of Non-Small Cell Lung Cancer Cells to Gefitinib and Reversal of Epithelial–Mesenchymal Transition by Aloe-Emodin Via PI3K/Akt/TWIS1 Signal Blockage
por: Peng, Minghui, et al.
Publicado: (2022)

Corrigendum: Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells
por: Gong, Baocheng, et al.
Publicado: (2022)

Corrigendum: Inflammatory Stress Potentiates Emodin-Induced Liver Injury in Rats
por: Tu, Can, et al.
Publicado: (2021)

Decreased Efficacy of Doxorubicin Corresponds With Modifications in Lipid Metabolism Markers and Fatty Acid Profiles in Breast Tumors From Obese vs. Lean Mice
por: Mentoor, Ilze, et al.
Publicado: (2020)

Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach
por: Tai, Yee Kit, et al.
Publicado: (2022)

Corrigendum: Somatic DNA damage response and homologous repair gene alterations and its association with tumor variant burden in breast cancer patients with occupational exposure to pesticides
por: Scandolara, Thalita Basso, et al.
Publicado: (2022)

Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway
por: Lin, Ke, et al.
Publicado: (2020)

Emodin Inhibits Inflammation, Carcinogenesis, and Cancer Progression in the AOM/DSS Model of Colitis-Associated Intestinal Tumorigenesis
por: Zhang, Yunsha, et al.
Publicado: (2021)

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer
por: Tian, Xin, et al.
Publicado: (2022)

Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers
por: Caldon, C. Elizabeth
Publicado: (2014)

MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers
por: Plantamura, Ilaria, et al.
Publicado: (2018)

Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes
por: Teng, Xu, et al.
Publicado: (2023)

Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ERα Inhibition
por: Huang, Pao-Hsuan, et al.
Publicado: (2013)

Cell Metabolomics Reveals the Potential Mechanism of Aloe Emodin and Emodin Inhibiting Breast Cancer Metastasis
por: Cheng, Guorong, et al.
Publicado: (2022)

Corrigendum: GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling
por: Booth, Laurence, et al.
Publicado: (2021)

Emodin-Induced Autophagy Against Cell Apoptosis Through the PI3K/AKT/mTOR Pathway in Human Hepatocytes [Corrigendum]
Publicado: (2022)

Doxorubicin-induced cardiotoxicity is mediated by neutrophils through release of neutrophil elastase
por: Bhagat, Anchit, et al.
Publicado: (2022)

Forced Degradation Studies of Aloe Emodin and Emodin by HPTLC
por: Narayanan, Sindhu, et al.
Publicado: (2015)

The Comparison of the Efficiency of Emodin and Aloe-Emodin in Photodynamic Therapy
por: Nowak-Perlak, Martyna, et al.
Publicado: (2022)

Salvia chinensis Benth Inhibits Triple-Negative Breast Cancer Progression by Inducing the DNA Damage Pathway
por: Wang, Kai-nan, et al.
Publicado: (2022)

Targeting ATM-deficient CLL through interference with DNA repair pathways
por: Knittel, Gero, et al.
Publicado: (2015)

Corrigendum: EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways
por: Pan, Hongda, et al.
Publicado: (2021)

Emodin-Mediated Treatment of Acute Kidney Injury
por: Liu, Yu, et al.
Publicado: (2022)

Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin
por: Joyce, M. Hunter, et al.
Publicado: (2018)

Antitumorigenic Effect of Tramadol and Synergistic Effect With Doxorubicin in Human Breast Cancer Cells
por: Huang, Yi-Hsuan, et al.
Publicado: (2022)

IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer
por: Hum, Nicholas R., et al.
Publicado: (2022)

YBX3 Mediates the Metastasis of Nasopharyngeal Carcinoma via PI3K/AKT Signaling
por: Fan, Xiaoqin, et al.
Publicado: (2021)

Uncoupling DNA damage from chromatin damage to detoxify doxorubicin
por: Qiao, Xiaohang, et al.
Publicado: (2020)

Medulloblastoma and the DNA Damage Response
por: McSwain, Leon F., et al.
Publicado: (2022)

Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights
por: Du, Jiajia, et al.
Publicado: (2021)

A Case of Metaplastic Breast Cancer with Prolonged Response to Single Agent Liposomal Doxorubicin
por: Hamad, Lamya, et al.
Publicado: (2016)

STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
por: Li, Zhaoqing, et al.
Publicado: (2021)

Proton-induced DNA damage promotes integration of foreign plasmid DNA into human genome
por: Katerji, Meghri, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m0tnc4akl37c9bfhei81i6qtti